Find your next paid study

ECOG-ACRIN Cancer Research GroupNCT04423211

~$10 – $7,500

Prostate CarcinomaRecurrent Prostate Carcinoma

A Phase II Randomized Study of Interventions for Metabolic Protection Against Cardiometabolic Toxicity During Androgen Deprivation Therapy (IMPACT-ADT)

This phase II trial compares the effect of time-restricted eating (TRE) and glucagon-like peptide-1 (GLP1) receptor agonists (RA), semaglutide and tirzepatide,…

City of Hope Medical CenterNCT07202247

Molecular Correlates of Sensitivity and Resistance to Therapy in Genitourinary Malignancy

This study collects and studies tissue and blood samples from patients with prostate or bladder/urothelial cancer that has recurred (come back) at or near the …

Localized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more

University of WashingtonNCT01050504

~$10 – $750

Recurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate CancerCastration-resistant Prostate Cancer+1 more

MC230502 Dynamic Investigator Initiated Enterprise (DIVINE) in Prostate Cancer

This phase II trial studies the effects of stereotactic body radiation therapy (SBRT) and the timing of treatment with androgen receptor pathway inhibitor (ARP…

Prostate CarcinomaRecurrent Prostate Carcinoma

Mayo ClinicNCT06378866

Phase 1

99mTc-PSMA-I&Amp;S in Patients With Prostate Cancer: An Exploratory Biodistribution Study With Histopathology Validation

This exploratory study conducted under the RDRC program studies the biodistribution of 99mTc-PSMA-I\&S in patients with prostate cancer who undergo pelvic lymp…

Jonsson Comprehensive Cancer CenterNCT04857502

Phase 1

ENLIGHTEN: Detection by POSLUMA Following Negative Other PET-PSMA Imaging

This phase II trial evaluates an imaging technique (rhPSMA-7.3 positron emission tomography \[PET\]/computed tomography \[CT\]) for detecting prostate cancer i…

Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma

Northwestern UniversityNCT06813898

Phase 1

MC210501 Differences in Immunological Effects of Vitamin D Replacement Among Black/ African American (AA) Prostate Cancer Patients With Localized Versus Metastatic Disease

This early phase I is to find out how common vitamin D insufficiency is among African American patients with a history of prostate cancer that has not spread t…

Localized Prostate CarcinomaStage IV Prostate Cancer AJCC v8Locally Recurrent Prostate Carcinoma+1 more

Mayo ClinicNCT05045066

Biochemically Recurrent Prostate CarcinomaLocally Advanced Prostate CarcinomaMetastatic Prostate Carcinoma+2 more

A Phase 2 Pragmatic Clinical Trial to Evaluate Administration of Cancer Therapy in the Patients' Homes Versus in Clinic in Black Men With Advanced or Metastatic Prostate Cancer

This phase II trial evaluates the impact of cancer therapy in the patients' home compared to in the clinic on safety, side effects, patient preference, and sat…

Mayo ClinicNCT07073794

Biochemically Recurrent Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Supervised Exercise Program and Continuous Fitbit Monitoring

This phase II trial studies how well an exercise program and continuous Fitbit monitoring work for managing metabolic syndrome and cardiovascular disease risk …

M.D. Anderson Cancer CenterNCT05054296

Phase 3

Randomized Controlled Trial of Leuprolide Plus Abiraterone Acetate (AA) Versus Relugolix Plus AA for Advanced Prostate Cancer: The REVELUTION-2 Trial

This phase III/IV trial compares the impact of leuprolide and abiraterone acetate (AA) versus relugolix and AA on the heart in hormone-naive patients with adva…

Recurrent Prostate CarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8